Status:
COMPLETED
Intensive Therapies in Children With Hemiplegia
Lead Sponsor:
University of Salamanca
Conditions:
Infantile Hemiplegia
Eligibility:
All Genders
5-10 years
Phase:
NA
Brief Summary
This is a comparative study where two protocols of intensive therapies will be applied to study the improvements in the functional performance of the affected upper limb of children with hemiparesis a...
Detailed Description
the intervention protocols combine different doses of intensive therapy, being 80 hours of modified constraint induced movement therapy followed by 20 hours for protocol 1 and protocol 2 would be the ...
Eligibility Criteria
Inclusion
- Children diagnosed with Unilateral Infantile Cerebral Palsy, Congenital Infantile Hemiparesis.
- Ages between 5 to 10 years.
- Levels of I-III within the , manual ability classification system, MACS.
- Levels of I-III within the gross motor function classification system, GMFCS
Exclusion
- \- Diseases not associated with infantile hemiparesis.
- Low cognitive level to understand the execution of activities.
- Surgeries of the upper extremity during the 6 months prior to the intervention.
- Structured contractures in the affected upper extremity that cause functional impotence.
- Botulinum toxin two months prior to the intervention and application of it during the treatment.
- Epilepsy not controlled pharmacologically
Key Trial Info
Start Date :
October 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2019
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT03465046
Start Date
October 15 2018
End Date
January 30 2019
Last Update
November 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rocío Palomo Carrión
Torrijos, Toledo, Spain, 45500